Orgenesis Inc (ORGS)
0.4806
-0.03
(-5.76%)
USD |
NASDAQ |
May 22, 16:00
0.4806
0.00 (0.00%)
After-Hours: 20:00
Orgenesis Net Income (Quarterly): -6.623M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.623M |
| September 30, 2023 | -3.725M |
| June 30, 2023 | -25.54M |
| March 31, 2023 | -19.47M |
| December 31, 2022 | -4.097M |
| September 30, 2022 | -1.356M |
| June 30, 2022 | -5.427M |
| March 31, 2022 | -4.009M |
| December 31, 2021 | -5.016M |
| September 30, 2021 | -10.16M |
| June 30, 2021 | -2.659M |
| March 31, 2021 | -0.219M |
| December 31, 2020 | -46.04M |
| September 30, 2020 | -2.427M |
| June 30, 2020 | -20.41M |
| March 31, 2020 | 69.98M |
| December 31, 2019 | -6.06M |
| September 30, 2019 | -4.549M |
| June 30, 2019 | -5.201M |
| March 31, 2019 | -8.311M |
| November 30, 2018 | -4.996M |
| August 31, 2018 | -5.07M |
| May 31, 2018 | -2.614M |
| February 28, 2018 | -5.611M |
| November 30, 2017 | 0.19M |
| Date | Value |
|---|---|
| August 31, 2017 | -3.94M |
| May 31, 2017 | -2.489M |
| February 28, 2017 | -6.126M |
| November 30, 2016 | -4.801M |
| August 31, 2016 | -2.644M |
| May 31, 2016 | -3.892M |
| February 29, 2016 | 0.225M |
| November 30, 2015 | -0.958M |
| August 31, 2015 | -1.616M |
| May 31, 2015 | -1.097M |
| February 28, 2015 | -0.79M |
| November 30, 2014 | 0.4936M |
| August 31, 2014 | -3.492M |
| May 31, 2014 | -1.796M |
| February 28, 2014 | -0.7093M |
| November 30, 2013 | -1.715M |
| August 31, 2013 | -0.9374M |
| May 31, 2013 | -1.557M |
| February 28, 2013 | -1.330M |
| November 30, 2012 | -1.394M |
| August 31, 2012 | -1.875M |
| May 31, 2012 | -0.8748M |
| February 29, 2012 | -0.8539M |
| November 30, 2011 | -0.0619M |
| August 31, 2011 | -0.0027M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-46.04M
Minimum
Dec 2020
69.98M
Maximum
Mar 2020
-5.421M
Average
-5.016M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Altimmune Inc | -24.39M |
| Verastem Inc | -33.86M |
| Oragenics Inc | -2.451M |
| Actinium Pharmaceuticals Inc | -8.67M |
| Dare Bioscience Inc | -6.755M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.165M |
| Total Expenses (Quarterly) | 5.467M |
| EPS Diluted (Quarterly) | -0.21 |
| Enterprise Value | 38.97M |
| Gross Profit Margin (Quarterly) | 1.82% |
| Profit Margin (Quarterly) | -4.01K% |
| Earnings Yield | -407.8% |
| Normalized Earnings Yield | -368.50 |